StemGen

StemGen EBITDA per Share

EBITDA per Share of StemGen (SGNI) as of Nov 10, 2026.

EBITDA per Share

-0.00USD

YoY

175.85%

Last updated:

EBITDA per Share of StemGen is 2021 -0.00 USD. EBITDA per Share of StemGen was 2020 -0.00 USD. It decreases by 175.85% lower compared to the previous year.

The StemGen EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2014
-0.01 USD
Jan 1, 2015
-0.03 USD
Jan 1, 2016
-0.01 USD
Jan 1, 2017
0.00 USD
Jan 1, 2018
-0.00 USD
Jan 1, 2019
-0.00 USD
Jan 1, 2020
-0.00 USD
Jan 1, 2021
-0.00 USD
The StemGen EBITDA per Share history
YEAREBITDA per ShareYoY
-0.00USD+175.85%
-0.00USD-74.09%
-0.00USD+75.51%
-0.00USD-528.20%
0.00USD-107.17%
-0.01USD-78.48%
-0.03USD+590.83%
-0.01USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

StemGen Stock analysis

What does StemGen do? StemGen Inc. is a biotechnology company founded in 2005, headquartered in California, USA. The company specializes in the development and research of stem cell products for medical purposes. StemGen Inc. is one of the leading companies in the field of stem cell research. StemGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about StemGen stock

On Eulerpool you can find the complete historical development of EBITDA per Share StemGen since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — StemGen

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — StemGen